[release] Vascular Therapies Announces Positive Preliminary Clinical Results from its AV...

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Sep 10, 2019 at 9:52 AM.

  1. #1 cafead, Sep 10, 2019 at 9:52 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,973
    Likes Received:
    3
    via CRESSKILL, N.J., September 5, 2019 /PRNewswire/ -- Vascular Therapies, a clinical stage biotechnology company, is developing Sirogen™, a proprietary sirolimus formulation for intraoperative local, perivascular drug delivery focused on improving vascular access outcomes in patients with kidney disease. Daniel G. Clair, MD, vascular surgeon and Chairman of the Department of Surgery at Palmetto Health-USC Medical Group in Columbia, South Carolina presented preliminary results from the company’s clinical development program at the recent Eastern Vascular Society Meeting in Pittsburg, Pennsylvania.

    article source
     
    Quote

Reply to Thread